Genome-Wide DNA Methylation Profiling in Patients with Hypertension and Asymptomatic Intracranial Atherosclerotic Stenosis

Clicks: 30
ID: 329582
2026
Free PDF
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Emerging

Ranked #33 of 87 articles by views in American Journal of Hypertension

Most read Least read

Bar heights use a square-root scale.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
BACKGROUND: Hypertension is a major risk factor for intracranial atherosclerotic stenosis (ICAS), a leading cause of ischemic stroke in Asian populations. However, conventional risk factors only partially account for the pathogenesis of ICAS, underscoring the potential roles of epigenetic mechanisms. METHODS: We performed genome-wide DNA methylation profiling of 218 Chinese patients with hypertension using an Illumina Infinium Methylation EPIC 850K BeadChip. Identified differentially methylated positions (DMPs) were validated via pyrosequencing in 281 patients without asymptomatic ICAS (aICAS) who underwent a 4.7-year follow-up, among whom 79 developed new onset aICAS during follow-up. RESULTS: After quality control, 725,736 CpG sites were analyzed, identifying 28 DMPs (|Δβ| ≥ 0.06, FDR < 0.01) that were annotated to 16 genes. Interferon regulatory factor 1 (IRF1) showed significant hypermethylation at cg00255919 and cg21138405. Receiver operating characteristic curve analysis revealed that incorporating cg00255919 into conventional risk factors elevated the area under the curve (AUC) from 0.649 to 0.741 (P = 0.005). Pyrosequencing confirmed that cg00255919 hypermethylation was associated with a higher incidence of aICAS (adjusted HR = 1.99, 95% CI = 1.2-3.3). Kyoto Encyclopedia of Genes and Genomes analysis linked the DMPs to immune response pathways. CONCLUSIONS: This study identified novel methylation signatures for aICAS in patients with hypertension, highlighting IRF1 methylation as a potential biomarker for auxiliary screening.
Reference Key
openalex_W7214104250 Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Min Zhu, Zhang Jin, Jing Ma, Qin Wang, Yan Wang, Dingliang Zhu
Are you one of these authors? Claim your profile
Journal American Journal of Hypertension
Year 2026
DOI
10.1093/ajh/hpag117
URL
https://doi.org/10.1093/ajh/hpag117
Keywords Keywords not found

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.